RECRUITING

Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will enroll 120 women living with ovarian cancer following completion of initial treatment. Our objective is to test an intervention designed to provide support during the survivorship transition for this population, who live with a high degree of morbidity related to the illness and its treatment as well as a high risk of recurrence. Study participants will be randomly assigned to receive survivorship care using the POSTCare-O process or usual care. The primary outcome is quality of life at 12 weeks after intervention.

Official Title

POSTCARE-O: Survivorship Care for Women Living With Ovarian Cancer

Quick Facts

Study Start:2023-10-01
Study Completion:2027-04-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05752448

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Stage 2-4 ovarian cancer
  2. * Treated with some combination of surgery, chemotherapy, biologics, maintenance therapy
  3. * Within 6 months of completion of initial treatment (continued maintenance therapy okay)
  4. * Able to provide consent in English or Spanish
  1. * Admission to hospice at the completion of treatment for ovary cancer

Contacts and Locations

Study Contact

Nimrah Saleem, MPH
CONTACT
713-798-2272
nsaleem@bcm.edu
Judy Bettencourt, MPH
CONTACT
(713) 500-9527
judith.l.bettencourt@uth.tmc.edu

Principal Investigator

Elizabeth Kvale, MD,MPH
PRINCIPAL_INVESTIGATOR
Baylor College of Medicine

Study Locations (Sites)

UT Southwestern Parkland Health and Hospital System
Dallas, Texas, 75235
United States
Dan L Duncan Comprehensive Cancer Center at the O'Quinn Medical Tower at Baylor St. Luke's Medical Center
Houston, Texas, 77030
United States
Harris Health Smith Clinic
Houston, Texas, 77054
United States

Collaborators and Investigators

Sponsor: Baylor College of Medicine

  • Elizabeth Kvale, MD,MPH, PRINCIPAL_INVESTIGATOR, Baylor College of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-01
Study Completion Date2027-04-15

Study Record Updates

Study Start Date2023-10-01
Study Completion Date2027-04-15

Terms related to this study

Keywords Provided by Researchers

  • Ovarian Cancer
  • Survivorship
  • Cancer Survivor
  • Depression
  • Palliative Care
  • Quality of Life

Additional Relevant MeSH Terms

  • Ovarian Neoplasm
  • Depressive Symptoms
  • Quality of Life